Calamos Wealth Management LLC purchased a new position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 21,555 shares of the semiconductor company’s stock, valued at approximately $10,635,000.
Other hedge funds also recently modified their holdings of the company. Independence Bank of Kentucky raised its holdings in Synopsys by 120.0% during the second quarter. Independence Bank of Kentucky now owns 55 shares of the semiconductor company’s stock worth $28,000 after acquiring an additional 30 shares in the last quarter. Princeton Global Asset Management LLC increased its position in shares of Synopsys by 481.8% during the 2nd quarter. Princeton Global Asset Management LLC now owns 64 shares of the semiconductor company’s stock worth $33,000 after purchasing an additional 53 shares during the last quarter. AlphaQuest LLC raised its stake in shares of Synopsys by 423.1% during the 2nd quarter. AlphaQuest LLC now owns 68 shares of the semiconductor company’s stock worth $35,000 after purchasing an additional 55 shares in the last quarter. DiNuzzo Private Wealth Inc. boosted its holdings in shares of Synopsys by 266.7% in the 3rd quarter. DiNuzzo Private Wealth Inc. now owns 77 shares of the semiconductor company’s stock valued at $38,000 after buying an additional 56 shares during the last quarter. Finally, Whipplewood Advisors LLC boosted its holdings in shares of Synopsys by 203.7% in the 2nd quarter. Whipplewood Advisors LLC now owns 82 shares of the semiconductor company’s stock valued at $42,000 after buying an additional 55 shares during the last quarter. Institutional investors own 85.47% of the company’s stock.
Synopsys Stock Down 0.9%
Synopsys stock opened at $474.49 on Wednesday. The stock has a market cap of $90.78 billion, a P/E ratio of 59.39, a P/E/G ratio of 3.99 and a beta of 1.16. The company has a quick ratio of 1.52, a current ratio of 1.62 and a debt-to-equity ratio of 0.48. Synopsys, Inc. has a twelve month low of $365.74 and a twelve month high of $651.73. The company’s 50-day moving average price is $438.40 and its two-hundred day moving average price is $503.48.
Analysts Set New Price Targets
Several analysts have issued reports on the stock. JPMorgan Chase & Co. upped their price target on shares of Synopsys from $600.00 to $650.00 and gave the stock an “overweight” rating in a research report on Thursday, December 11th. Wells Fargo & Company upped their target price on shares of Synopsys from $445.00 to $500.00 and gave the company an “equal weight” rating in a report on Thursday, December 11th. Needham & Company LLC raised their target price on shares of Synopsys from $550.00 to $580.00 and gave the company a “buy” rating in a research note on Thursday, December 11th. BNP Paribas assumed coverage on Synopsys in a research report on Thursday, October 2nd. They set an “underperform” rating and a $425.00 price target on the stock. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Synopsys in a research report on Wednesday, October 8th. Eleven equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $562.13.
Get Our Latest Analysis on Synopsys
Insider Buying and Selling at Synopsys
In other news, CFO Shelagh Glaser sold 3,657 shares of the business’s stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $460.77, for a total value of $1,685,035.89. Following the completion of the sale, the chief financial officer owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. The trade was a 17.01% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 0.62% of the company’s stock.
Synopsys Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Articles
- Five stocks we like better than Synopsys
- Do not delete, read immediately
- The Crash Has Already Started (Most Just Don’t See It Yet)
- ALERT: Drop these 5 stocks before January 2026!
- [No Brainer Gold Play]: “Show me a better investment.”
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
